# Skleo Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/skleo-health

- Industry: Healthcare Specialists
- Headquarters: Düsseldorf, Germany
- Website: www.skleo.de
- Total disclosed funding: $3.4M
- Latest round: Seed (Jun 5, 2025)
- Investors on record: 2

## About

Skleo Health GmbH, based in Germany, focuses on developing digital healthcare solutions that enhance access to medical services for individuals, irrespective of their location or insurance status.Skleo Health GmbH is a company that specializes in digital healthcare solutions aimed at improving access to medical services. Founded in 2024 and headquartered in Düsseldorf, Germany, it has undergone a strategic pivot towards digitalization in healthcare. The company has received funding through a SEED round in July 2025, raising EUR 3 million, led by Sanoptis AG with participation from Antler. Skleo Health has completed 1 deal to date, with a total amount raised of EUR 3 million.Skleo Health GmbH specializes in developing digital solutions aimed at making healthcare accessible to a wider audience, regardless of geographical location, insurance status, or social circumstances. The company's core offerings include innovative healthcare platforms designed to facilitate low-barrier access to medical services, empowering users to engage with healthcare providers more effectively. These solutions are tailored to address various use cases, such as remote consultations, health management, and patient education, thereby enhancing overall health outcomes. Skleo Health targets markets across Europe, with a particular focus on urban and rural areas that exhibit significant disparities in healthcare access. Its client base encompasses both individual users seeking healthcare solutions and healthcare providers looking to leverage technology for improved service delivery.Skleo Health's revenue model is structured around partnerships and direct-to-consumer transactions, where clients can access a range of digital health services. The company generates income through subscription plans that cater to both individual consumers and healthcare providers, allowing users to benefit from ongoing access to their services. Specific pricing plans for these subscriptions are set to ensure affordability while maintaining service quality. The flagship products are designed to integrate seamlessly into existing healthcare infrastructures, promoting widespread adoption among providers. Revenue transaction structures involve a combination of upfront fees for initial service activation and recurring monthly or annual charges, fostering sustained engagement with their user base and enhancing overall service utilization.Skleo Health GmbH plans to utilize the EUR 3 million raised in the SEED funding round to support its expansion efforts. The company aims to design and launch new healthcare solutions that enhance user engagement and service delivery in the upcoming year. Additionally, Skleo Health is strategizing to expand its presence into new European markets by mid-2026, targeting regions with significant healthcare accessibility challenges.

## Funding rounds

- Seed, Jun 5, 2025, $3.4M — Antler, Sanoptis AG

## Investors

- Antler (https://capitalatlas.ai/funds/antler) — Seed
- Sanoptis AG — Seed